Three-Year Outcomes Following TAVR in Younger (<75 Years) Low-Surgical-Risk Severe Aortic Stenosis Patients
Thomas Modine(Université de Bordeaux), Michael J. Reardon(Houston Methodist), Nicolas M. Van Mieghem(Erasmus MC), Rodrigo Bagur, Rik Adrichem(Erasmus MC), Michael Chu(University of Michigan), Basel Ramlawi, Ayman Iskander(St Joseph's Hospital Health Center), John Crouch(Aurora St. Luke's Medical Center), Hemal Gada(University of Pittsburgh Medical Center), G. Michael Deeb(Michigan Medicine), Neal S. Kleiman(Houston Methodist), John K. Forrest(Yale University), Arnaud Sudre, Tanvir Bajwa(Aurora Health Care), Stanley Chetcuti(University of Michigan), Paul Sorajja(Abbott Northwestern Hospital), Saki Ito(Mayo Clinic in Arizona), Jeffrey J. Popma(Cardiovascular Research Foundation), Didier Tchétché(Clinique Pasteur), Jian Huang(Medtronic (United States)), Mubashir Mumtaz(University of Pittsburgh Medical Center), Steven J. Yakubov(OhioHealth), Paul S. Teirstein(Scripps Health), Pierre Berthoumieu(Clinique Pasteur)
Cited by 10
Related Papers
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
|New England Journal of Medicine|2019|3.6k
Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis
|New England Journal of Medicine|2010|3k
Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients
|New England Journal of Medicine|2004|2.9k
Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement
|New England Journal of Medicine|2012|2.3k